DMII (Drugs Made In America Acquisition II) 6-Month Price Index: 1.02 (As of Jul. 11, 2026)


DMII Drugs Made In America Acquisition II Corp DMII
15 GF Score
Price $10.10
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition II 6-Month Price Index?

Drugs Made In America Acquisition II DMII 15 6-Month Price Index is 1.02 as of Jul. 11, 2026. GuruFocus rates DMII with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-07-11), Drugs Made In America Acquisition II's 6-Month Price Index is 1.02.

Drugs Made In America Acquisition II  (NAS:DMII) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Drugs Made In America Acquisition II 6-Month Price Index Related Terms

DMII vs BCSS, EVAC, CEPF: 6-Month Price Index Comparison

For the Shell Companies subindustry, Drugs Made In America Acquisition II's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DMII
15GF Score
Drugs Made In America Acquisition II Corp DMII
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition II  (NAS:DMII) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 1.02 mean?
Drugs Made In America Acquisition II (DMII) has a 6-Month Price Index of 1.02 as of Jul. 11, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Drugs Made In America Acquisition II and its competitors.
Is Drugs Made In America Acquisition II's 6-Month Price Index too high?
Drugs Made In America Acquisition II's current 6-Month Price Index is 1.02. Overall, Drugs Made In America Acquisition II has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition II's 6-Month Price Index compare to BCSS and EVAC?
Drugs Made In America Acquisition II's 6-Month Price Index of 1.02 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Diversified Financial Services company?
A good 6-Month Price Index depends on the Diversified Financial Services industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Drugs Made In America Acquisition II and its competitors. Drugs Made In America Acquisition II's current 6-Month Price Index is 1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition II stock overvalued right now?
Drugs Made In America Acquisition II (DMII) has a current 6-Month Price Index of 1.02. The current 6-Month Price Index is 1.02. Drugs Made In America Acquisition II's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Drugs Made In America Acquisition II (DMII), the current 6-Month Price Index is 1.02 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition II Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition II Corp is a blank check Company.
15GF Score

Get the complete analysis for DMII

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.10
Price